Keurig Dr Pepper (NYSE:KDP) Updates FY 2020 Pre-Market Earnings Guidance
Keurig Dr Pepper (NYSE:KDP) updated its FY 2020
Pre-Market earnings guidance on Thursday. The company provided earnings per share guidance of 1.38-1.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.38. The company issued revenue guidance of $11.454-11.565 billion, compared to the consensus revenue estimate of $11.42 billion.Keurig Dr Pepper also updated its FY20 guidance to $1.38-1.40 EPS.
A number of research analysts have recently issued reports on the company. SunTrust Banks reiterated a buy rating on shares of Keurig Dr Pepper in a research report on Wednesday, April 29th. Jefferies Financial Group increased their target price on Keurig Dr Pepper from $36.00 to $39.00 and gave the company a buy rating in a research report on Monday, July 27th. Citigroup increased their target price on Keurig Dr Pepper from $28.00 to $31.00 and gave the company a neutral rating in a research report on Tuesday, April 28th. Morgan Stanley increased their target price on Keurig Dr Pepper from $30.00 to $32.00 and gave the company an equal weight rating in a research report on Friday. Finally, Royal Bank of Canada reiterated a buy rating and set a $31.00 target price on shares of Keurig Dr Pepper in a research report on Thursday, April 30th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of Buy and an average target price of $33.63.
Shares of KDP stock opened at $30.59 on Friday. The stock’s fifty day moving average is $29.12 and its two-hundred day moving average is $27.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.23 and a current ratio of 0.31. The firm has a market capitalization of $43.04 billion, a P/E ratio of 23.71, a PEG ratio of 1.90 and a beta of 0.61. Keurig Dr Pepper has a fifty-two week low of $18.98 and a fifty-two week high of $32.00.
In related news, major shareholder Holdings B.V. Jab purchased 7,380,000 shares of Keurig Dr Pepper stock in a transaction dated Friday, May 22nd. The shares were acquired at an average price of $27.16 per share, for a total transaction of $200,440,800.00. Also, Director Robert S. Singer purchased 1,000 shares of Keurig Dr Pepper stock in a transaction dated Friday, June 12th. The shares were bought at an average price of $28.14 per share, for a total transaction of $28,140.00. Following the acquisition, the director now owns 65,500 shares in the company, valued at $1,843,170. The disclosure for this purchase can be found here. Company insiders own 0.41% of the company’s stock.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Featured Article: Yield Curve
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.